232 related articles for article (PubMed ID: 21059627)
1. Oxcarbazepine does not suppress cortical spreading depression.
Hoffmann U; Dileköz E; Kudo C; Ayata C
Cephalalgia; 2011 Apr; 31(5):537-42. PubMed ID: 21059627
[TBL] [Abstract][Full Text] [Related]
2. Migraine preventive drugs differentially affect cortical spreading depression in rat.
Bogdanov VB; Multon S; Chauvel V; Bogdanova OV; Prodanov D; Makarchuk MY; Schoenen J
Neurobiol Dis; 2011 Feb; 41(2):430-5. PubMed ID: 20977938
[TBL] [Abstract][Full Text] [Related]
3. Suppression of cortical spreading depression in migraine prophylaxis.
Ayata C; Jin H; Kudo C; Dalkara T; Moskowitz MA
Ann Neurol; 2006 Apr; 59(4):652-61. PubMed ID: 16450381
[TBL] [Abstract][Full Text] [Related]
4. Chronic daily cortical spreading depressions suppress spreading depression susceptibility.
Sukhotinsky I; Dilekoz E; Wang Y; Qin T; Eikermann-Haerter K; Waeber C; Ayata C
Cephalalgia; 2011 Dec; 31(16):1601-8. PubMed ID: 22013142
[TBL] [Abstract][Full Text] [Related]
5. Suppressive effect of chronic peroral topiramate on potassium-induced cortical spreading depression in rats.
Unekawa M; Tomita Y; Toriumi H; Suzuki N
Cephalalgia; 2012 May; 32(7):518-27. PubMed ID: 22523186
[TBL] [Abstract][Full Text] [Related]
6. Evidence for orexinergic mechanisms in migraine.
Hoffmann J; Supronsinchai W; Akerman S; Andreou AP; Winrow CJ; Renger J; Hargreaves R; Goadsby PJ
Neurobiol Dis; 2015 Feb; 74():137-43. PubMed ID: 25447225
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological targeting of spreading depression in migraine.
Eikermann-Haerter K; Can A; Ayata C
Expert Rev Neurother; 2012 Mar; 12(3):297-306. PubMed ID: 22364328
[TBL] [Abstract][Full Text] [Related]
8. Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.
Eikermann-Haerter K; Lee JH; Yalcin N; Yu ES; Daneshmand A; Wei Y; Zheng Y; Can A; Sengul B; Ferrari MD; van den Maagdenberg AM; Ayata C
Stroke; 2015 Jan; 46(1):229-36. PubMed ID: 25424478
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and mechanism of anticonvulsant drugs in migraine.
Hoffmann J; Akerman S; Goadsby PJ
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):191-201. PubMed ID: 24494792
[TBL] [Abstract][Full Text] [Related]
10. New insights into migraine pathophysiology.
Sanchez-Del-Rio M; Reuter U; Moskowitz MA
Curr Opin Neurol; 2006 Jun; 19(3):294-8. PubMed ID: 16702838
[TBL] [Abstract][Full Text] [Related]
11. The thalamic reticular nucleus is activated by cortical spreading depression in freely moving rats: prevention by acute valproate administration.
Tepe N; Filiz A; Dilekoz E; Akcali D; Sara Y; Charles A; Bolay H
Eur J Neurosci; 2015 Jan; 41(1):120-8. PubMed ID: 25327971
[TBL] [Abstract][Full Text] [Related]
12. Novel Therapeutic Targets Against Spreading Depression.
Chen SP; Ayata C
Headache; 2017 Oct; 57(9):1340-1358. PubMed ID: 28842982
[TBL] [Abstract][Full Text] [Related]
13. Effect of eugenol on spreading depression and epileptiform discharges in rat neocortical and hippocampal tissues.
Müller M; Pape HC; Speckmann EJ; Gorji A
Neuroscience; 2006 Jun; 140(2):743-51. PubMed ID: 16563641
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiology and neuromodulators.
Aguggia M; D'Andrea G; Bussone G
Neurol Sci; 2007 May; 28 Suppl 2():S97-S100. PubMed ID: 17508189
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization.
Vila-Pueyo M; Cuenca-León E; Queirós AC; Kulis M; Sintas C; Cormand B; Martín-Subero JI; Pozo-Rosich P; Fernàndez-Castillo N; Macaya A
Cephalalgia; 2023 Feb; 43(2):3331024221146317. PubMed ID: 36759321
[TBL] [Abstract][Full Text] [Related]
16. Vagus nerve stimulation inhibits cortical spreading depression.
Chen SP; Ay I; Lopes de Morais A; Qin T; Zheng Y; Sadeghian H; Oka F; Simon B; Eikermann-Haerter K; Ayata C
Pain; 2016 Apr; 157(4):797-805. PubMed ID: 26645547
[TBL] [Abstract][Full Text] [Related]
17. Behavior in the open field predicts the number of KCl-induced cortical spreading depressions in rats.
Bogdanov VB; Bogdanova OV; Koulchitsky SV; Chauvel V; Multon S; Makarchuk MY; Brennan KC; Renshaw PF; Schoenen J
Behav Brain Res; 2013 Jan; 236(1):90-93. PubMed ID: 22981717
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic Changes in Rat Cortex and Brainstem After Cortical Spreading Depression With or Without Pretreatment With Migraine Prophylactic Drugs.
Sintas C; Fernàndez-Castillo N; Vila-Pueyo M; Pozo-Rosich P; Macaya A; Cormand B
J Pain; 2017 Apr; 18(4):366-375. PubMed ID: 27919769
[TBL] [Abstract][Full Text] [Related]
19. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine.
Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF
J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580
[TBL] [Abstract][Full Text] [Related]
20. Tonabersat, a novel gap-junction modulator for the prevention of migraine.
Silberstein SD
Cephalalgia; 2009 Nov; 29 Suppl 2():28-35. PubMed ID: 19723123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
